Around two-thirds of patients treated for breast cancer will have had hormone-sensitive tumors and, after their initial treatment, will be advised to undergo hormone therapy for five to 10 years to prevent recurrence.
Feb 1, 2019
0
3
Despite clear directives outlined in the updated guidelines published by the American College of Rheumatology/National Psoriasis Foundation (ACR/NPF) in 2018, there is limited data regarding medication use in real-world clinical ...
Nov 9, 2021
0
1
For some cancers, initial treatment with chemotherapy brings positive, but only temporary, results: tumors shrink, but then rebound as the cancer becomes drug-resistant. This pattern of remission-resistance-relapse is particularly ...
Apr 4, 2019
0
43
Results of some preclinical trials have shown that low doses of the antidiabetic drug metformin may effectively destroy cancer stem cells, a group of cells that are considered to be responsible for tumor initiation and, because ...
Jun 19, 2012
0
6
Nearly 270,000 people in the United States are diagnosed with breast cancer each year.
Mar 9, 2023
0
67
Squamous cell carcinoma (SCC) represents the second most frequent skin cancer with more than half million new patients affected every year in the world. Cancer stem cells (CSCs), a population of cancer cells that have been ...
Jan 12, 2015
0
10
Researchers have identified two molecules that could potentially serve as biomarkers in predicting brain metastases in patients with breast cancer, according to data published in Cancer Research, a publication of the American ...
Feb 5, 2013
0
0
A cellular identity switch protects a cancer-promoting genetic pathway from targeted therapy, researchers at The University of Texas MD Anderson Cancer Center today reported in Science Translational Medicine.
Mar 13, 2019
0
20
A new experimental approach to treating a type of brain cancer called medulloblastoma has been developed by researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham). The method targets cancer stem cells—the ...
Sep 25, 2013
0
0
Though the two main histological types of breast cancer—lobular and ductal—are treated with the same hormonal therapies, women with lobular breast cancer often have recurrence or metastasis of the disease several years ...
Jul 28, 2021
0
4
